ENG/中
美国
老虎證券
行情
产品介绍
Cash Boost账户
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerGPT
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登入
立即註冊
Toggle
港股
詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務
高瓴概念
510.843
-19.317
-3.64%
手動刷新
漲家數:
8
跌家數:
43
平家數:
4
市盈率:
- -
高:
530.970
開:
530.107
低:
506.286
收:
530.160
資料載入中...
總覽
新聞
中紅醫療:子公司獲得醫療器械註冊證
证券
·
03-06
心通醫療-B預期2024年淨虧損同比收窄約87%至94%
格隆汇资讯
·
03-06
機構:歐洲央行如期降息避免引發市場動盪,未來不確定性仍存
金十财经
·
03-06
暴降70%!泰格醫藥閃崩,CRO失去最後避風港
市场资讯
·
03-06
心通醫療-B(02160)發盈警 預期2024年淨虧損約3000萬-6000萬元 同比減少約87%至94%
智通财经网
·
03-06
京東健康2024年業績超預期 總收入達到582億元
证券日报
·
03-06
高瓴大幅減持百濟神州:或套現50億 仍是重要股東
雷递网
·
03-06
富達國際減持海吉亞醫療(06078)113.48萬股 每股作價約16.83港元
智通财经
·
03-06
石藥集團:I類新藥雙功能融合蛋白藥物JMT108獲臨牀試驗批准
财经网
·
03-06
百濟神州股東減持3224萬股,持股比例降至6.66%
财中社
·
03-06
Bitwise在歐洲推出同時追蹤比特幣和黃金的ETP
Blockbeats
·
03-06
Bitwise 推出歐洲首個比特幣與黃金混合 ETP
金色财经
·
03-06
京東健康2024年總收入582億元
读创
·
03-06
京東健康2024年收入同比增長8.6% 互聯網醫院日均在線諮詢量超49萬
每日经济新闻
·
03-06
海底撈回應網傳有人往火鍋裏小便:公安機關已立案
新浪科技
·
03-06
海底撈背後的預製菜巨頭,一年狂攬百億
蓝鲸财经
·
03-06
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK1583/news?page=17"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1583"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","market":"HK","secType":"PLATE","nameCN":"高瓴概念","latestPrice":510.84283,"timestamp":1741594084374,"preClose":530.16,"halted":0,"volume":641110353,"delay":0,"changeRate":-0.036436,"change":-19.317139,"pbRate":2.561308,"amount":16897837474.6,"amplitude":0.04656,"prevYearClose":446.93042,"fiveDayClose":491.838,"twentyDayClose":478.478,"turnoverRate":0.004545,"marketCap":2846829146368,"floatMarketCap":2260124340224,"peRate":34.961436},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","high":530.9704,"amplitude":0.04656,"preClose":530.16,"low":506.28616,"pbRate":"2.561308","latestPrice":510.84283,"volume":641110353,"delay":0,"open":530.1071,"prevYearClose":446.93042,"prevWeekClose":530.16,"prevMonthClose":492.906,"prevQuarterClose":446.93,"fiveDayClose":491.838,"twentyDayClose":478.478,"sixtyDayClose":472.845,"secType":"PLATE","market":"HK","turnoverRate":0.004545,"peRate":34.961436,"marketCap":2846829146368,"floatMarketCap":2260124340224,"timestamp":1741594084374,"nameCN":"高瓴概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1583\",,,,undefined,":{"bkCode":"BK1583","up":8,"down":43,"flat":4},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1583\",pageSize:16,pageCount:17,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2517165045","title":"中紅醫療:子公司獲得醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2517165045","media":"证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517165045?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 22:08","pubTimestamp":1741270080,"startTime":"0","endTime":"0","summary":"证券日报网讯 3月6日晚间,中红医疗发布公告称,公司子公司深圳迈德瑞纳生物科技有限公司(简称“迈德瑞纳”)于近期取得了广东省药品监督管理局颁发的《中华人民共和国医疗器械注册证》,迈德瑞纳申报的肠内营养泵医疗器械注册证已审批通过。\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-03-06/doc-inenttpc3265800.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1100","BK1574","09997","BK1583","159883","BK1222","BK0220","09996","300981"],"gpt_icon":0},{"id":"2517168156","title":"心通醫療-B預期2024年淨虧損同比收窄約87%至94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517168156","media":"格隆汇资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517168156?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 21:58","pubTimestamp":1741269522,"startTime":"0","endTime":"0","summary":"格隆汇3月6日丨心通医疗-B公告,根据对集团截至2024年12月31日止年度未经审核管理账目的初步审阅及对董事会目前可得最新资料的评估,集团预期报告期录得净亏损约人民币3000万元至人民币6000万元,较截至2023年12月31日止年度减少约87%至94%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306215850989eaca2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306215850989eaca2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1100","02160","BK1574"],"gpt_icon":0},{"id":"2517150447","title":"機構:歐洲央行如期降息避免引發市場動盪,未來不確定性仍存","url":"https://stock-news.laohu8.com/highlight/detail?id=2517150447","media":"金十财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517150447?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 21:58","pubTimestamp":1741269483,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"0d6184e4d27e8e91b8b00e52597fd1b8","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://flash-api.jin10.com/get_flash_list?channel=2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_jinshicaijing","symbols":["BK1583","09983","HK0000934320.USD","BK1229","BK1258","BK1542"],"gpt_icon":0},{"id":"2517168193","title":"暴降70%!泰格醫藥閃崩,CRO失去最後避風港","url":"https://stock-news.laohu8.com/highlight/detail?id=2517168193","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517168193?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 21:58","pubTimestamp":1741269480,"startTime":"0","endTime":"0","summary":"AI浪潮袭来,CRO行业正从“人力密集型”向“技术驱动型”演进。行业结构性调整的阵痛,无人能幸免。药明、康龙化成之后,轮到CRO血统最纯正的大哥——泰格医药了。作为中国CXO行业“最后的堡垒”,CRO一哥终于顶不住了——2024年迎来了业绩创纪录式的大跌:根据预告,其上市以来年营收首次出现下滑;归母净利润预计同比骤降72%-81%,这一力度也是上市后首次,盈利压力凸显。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306221121989eafa8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306221121989eafa8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","BK1576","03347","BK1583"],"gpt_icon":0},{"id":"2517150236","title":"心通醫療-B(02160)發盈警 預期2024年淨虧損約3000萬-6000萬元 同比減少約87%至94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517150236","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517150236?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 21:55","pubTimestamp":1741269335,"startTime":"0","endTime":"0","summary":"心通医疗-B(02160)公布,该集团预期2024年取得净亏损约人民币3000万-...","market":"sh","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_37.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_37.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1258805.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1574","BK1100","02160","BK1583"],"gpt_icon":0},{"id":"2517150788","title":"京東健康2024年業績超預期 總收入達到582億元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517150788","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517150788?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 21:34","pubTimestamp":1741268092,"startTime":"0","endTime":"0","summary":"本报讯(记者袁传玺)3月6日,京东健康股份有限公司(以下简称“京东健康”)发布2024年全年业绩公告。2024年,京东健康总收入为582亿元,非国际财务报告准则指标下(Non-IFRS)净利润达47.9亿元,收入和净利润超过市场预期。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202503063338762475.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1142","BK1515","BK1589","86618","LU0051755006.USD","BK1583","LU0456827905.SGD","BK1591","BK1247","06618","BK1571"],"gpt_icon":0},{"id":"2517157675","title":"高瓴大幅減持百濟神州:或套現50億 仍是重要股東","url":"https://stock-news.laohu8.com/highlight/detail?id=2517157675","media":"雷递网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517157675?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 21:29","pubTimestamp":1741267769,"startTime":"0","endTime":"0","summary":"由于百济神州这两日股价处于低点,若以今日股价计算,高瓴套现50亿港元。这是2024年12月以来,高瓴再次减持百济神州。百济神州此前公告称,高瓴于2023年6月8日至 2024年12月2日通过集中竞价和大宗交易方式合计减持21,997,317股。百济神州年营收272亿近期,百济神州发布业绩快报。不过,过去半年的时间,百济神州股价持续上涨,高瓴则持续减持,共套现至少超过70亿港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306212955963c3dd5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306212955963c3dd5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1588","688235","LU2328871848.SGD","06160","BK1500","LU0307460666.USD","LU0588546209.SGD","LU1969619763.USD","BK1161","BK1583"],"gpt_icon":0},{"id":"2517531159","title":"富達國際減持海吉亞醫療(06078)113.48萬股 每股作價約16.83港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517531159","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517531159?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 20:19","pubTimestamp":1741263559,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,香港联交所最新资料显示,2月27日,富达国际减持海吉亚医疗(06078)113.48万股,每股作价16.8258港元,总金额约为1909.39万港元。减持后最新持股数目为3674.96万股,最新持股比例为5.91%。本交易涉及其他关联方:Pandanus Associates Inc.和Pandanus Partners L.P.。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1258747.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["YMM","BK4503","06078","BK4232","LU0329678170.USD","LU2242644610.SGD","BK4526","LU0456842615.SGD","LU0502904849.HKD","BK4539","BK4548","LU0327786744.USD","LU0737861772.HKD","BK1583","LU2488822045.USD","BK1209","BK4022","LU0572944931.SGD","LU0329678337.USD","LU0455707207.USD"],"gpt_icon":0},{"id":"2517445159","title":"石藥集團:I類新藥雙功能融合蛋白藥物JMT108獲臨牀試驗批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2517445159","media":"财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517445159?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 19:58","pubTimestamp":1741262311,"startTime":"0","endTime":"0","summary":"近日,石药集团发布JMT108获中国临床试验批准的公告。该产品是一种重组全人源抗PD-1且融合IL-15的双功能融合蛋白,通过靶向PD-1阳性肿瘤浸润免疫细胞,解除PD-1和PD-L1相互作用导致的免疫抑制,并通过PD-1抗体结合依赖性地激活IL-15下游信号通路,进一步促进相关免疫细胞的增殖和活化,从而达到增强的抗肿瘤疗效。本次获批的临床适应症为晚期恶性肿瘤。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306200013abeb4e69&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306200013abeb4e69&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1152091754.HKD","IE00BZ08YR35.GBP","01093","IE00BZ08YT58.USD","BK1583","LU1226287529.USD","LU1152091168.USD","LU1008478684.HKD","LU1960683339.HKD","IE00B543WZ88.USD","LU1226287875.USD","LU0067412154.USD","LU1226288253.USD","BK1576","IE00BZ08YS42.EUR","BK1521","IE00B5MMRT66.SGD","IE00B031HY20.USD","BK1191","LU0140636845.USD","IE0008368742.USD","LU1807302812.USD","IE0008369823.USD","LU0326950275.SGD","LU1226288170.HKD","LU1993786604.SGD","LU1951186391.HKD","BK1141","SG9999004220.SGD","03347","LU0072913022.USD","LU0880133367.SGD","LU1226287792.SGD","BK1515","LU0501845795.SGD"],"gpt_icon":0},{"id":"2517155469","title":"百濟神州股東減持3224萬股,持股比例降至6.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517155469","media":"财中社","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517155469?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 19:40","pubTimestamp":1741261203,"startTime":"0","endTime":"0","summary":"3月6日,百济神州发布公告,股东HHLR Fund,L.P.及其联属实体于2025年3月3日至3月4日通过大宗交易方式合计减持公司境外流通股股份3224万股。本次权益变动后,HHLR Fund,L.P.及其联属实体持有公司股份数量从1.25亿股减少至9281万股,所持股份占公司已发行股份总数的比例从8.97%减少至6.66%。此次减持不触及要约收购,且公司无控股股东、无实际控制人的状态未发生变化。2024年前三季度,百济神州实现收入191.36亿元,归母净利润-36.87亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306194014963c1ee6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306194014963c1ee6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06160","BK1500","LU1969619763.USD","LU0588546209.SGD","BK1588","LU2328871848.SGD","688235","LU0307460666.USD","BK1583"],"gpt_icon":0},{"id":"2517155427","title":"Bitwise在歐洲推出同時追蹤比特幣和黃金的ETP","url":"https://stock-news.laohu8.com/highlight/detail?id=2517155427","media":"Blockbeats","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517155427?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 19:38","pubTimestamp":1741261080,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theblockbeats.info//flash/284425","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"theblockbeats_zh_live","symbols":["BK1542","BK4588","09983","09042","159831","SGUmain","BK4601","BTC","DUST","BK1229","IBIT","03439","09439","MSTU","BK1611","BK1258","83042","BK1583","SGCmain","BK4585","09008","518880","BK4594","GLD","BTC.USD.HKCC","NUGT","03008","BTCmain","GCmain","XBTmain","BTC.USD.CC","03042","159934","IAU","MGCmain","GDX"],"gpt_icon":0},{"id":"2517530881","title":"Bitwise 推出歐洲首個比特幣與黃金混合 ETP","url":"https://stock-news.laohu8.com/highlight/detail?id=2517530881","media":"金色财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517530881?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 19:31","pubTimestamp":1741260707,"startTime":"0","endTime":"0","summary":null,"market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.coindesk.com/markets/2025/03/06/bitwise-debuts-bitcoin-and-gold-etp-in-europe","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinse_live","symbols":["NUGT","03042","GCmain","MGCmain","03008","BK4588","GLD","BK1611","BTCmain","BK4585","BK1229","518880","83042","SGCmain","GDX","03439","BTC.USD.CC","IBIT","BK1258","XBTmain","BK1583","159831","159934","09008","SGUmain","DUST","MSTU","BTC.USD.HKCC","BK1542","IAU","BK4601","BTC","BK4594","09042","09983","09439"],"gpt_icon":0},{"id":"2517246155","title":"京東健康2024年總收入582億元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517246155","media":"读创","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517246155?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 19:31","pubTimestamp":1741260668,"startTime":"0","endTime":"0","summary":"深圳商报·读创客户端记者陈姝3月6日,京东健康发布2024年全年业绩公告显示,2024年总收入为人民币582亿元,非国际财务报告准则指标下(Non-IFRS)净利润达47.9亿元。2024年以来,依托“京医千询”医疗大模型,京东健康持续推动医疗AI落地,率先实现了大模型在医疗健康行业规模化、全场景的应用。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202503063338696418.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1247","LU0456827905.SGD","BK1583","LU0051755006.USD","06618","BK1589","BK1515","BK1142","BK1591","86618","BK1571"],"gpt_icon":0},{"id":"2517552241","title":"京東健康2024年收入同比增長8.6% 互聯網醫院日均在線諮詢量超49萬","url":"https://stock-news.laohu8.com/highlight/detail?id=2517552241","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517552241?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 19:29","pubTimestamp":1741260587,"startTime":"0","endTime":"0","summary":"3月6日,京东健康(HK06618,股价40.800港元,市值1305亿港元)发布2024年全年业绩公告,公司全年总收入为581.60亿元,同比增长8.6%,年度盈利41.57亿元,同比增长94%,非国际财务报告准则指标下(Non-IFRS)净利润为47.9亿元,同比增长15.9%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202503063338695786.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202503063338695786.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1142","BK1591","BK1247","BK1583","BK1589","06618","LU0051755006.USD","BK1571","LU0456827905.SGD","86618","BK1515"],"gpt_icon":0},{"id":"2517775158","title":"海底撈回應網傳有人往火鍋裏小便:公安機關已立案","url":"https://stock-news.laohu8.com/highlight/detail?id=2517775158","media":"新浪科技","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517775158?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 18:57","pubTimestamp":1741258620,"startTime":"0","endTime":"0","summary":"新浪科技讯 3月6日晚间消息,近日,有网友分享了多条视频显示,疑有男子站在桌子上向火锅小便。\n 对此,海底捞官方回应称,“就此视频片段,公安机关已立案,我们全力配合相关部门溯源追查,无论是否摆拍,都将依法坚决追究涉事人员法律责任。同时恳请理性监督,不传播此类视频,共同维护清朗网络空间。”\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:何俊熹","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/tech/2025-03-06/doc-inenthxi3471391.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1604","BK1233","BK1583","LU2488822045.USD","BK1591","BK1589","06862"],"gpt_icon":0},{"id":"2517302821","title":"海底撈背後的預製菜巨頭,一年狂攬百億","url":"https://stock-news.laohu8.com/highlight/detail?id=2517302821","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517302821?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 18:37","pubTimestamp":1741257430,"startTime":"0","endTime":"0","summary":"站在海底捞、张亮麻辣烫等企业背后的安井食品,1月20日向港交所递交招股书,计划实现A+H双重上市,再次让预制菜成为话题中心。但到了2024年上半年,安井预制菜增速大幅速降至0.4%,几乎陷入零增长。到了2023年上半年,安井食品的预制菜业务更是首次超越火锅料板块,成为其第一大营收板块。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/252353","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK1233","BK1583","BK1604","BK1591","06862","LU2488822045.USD","BK1589"],"gpt_icon":0}],"pageSize":16,"totalPage":65,"pageCount":17,"totalSize":1027}]}}